Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Oropharyngeal Neoplasms 4Head and Neck Neoplasms 3Rectal Neoplasms 2Pathologic Complete Response 2Lung Neoplasms 2Glioblastoma 2Uterine Cervical Neoplasms 1Tobacco Use Disorder 1Thymoma 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Smoking Cessation 1Smoking 1Sinonasal Squamous Cell Carcinoma 1Rectal Malignant Neoplasms 1Radiation Injuries 1Postoperative Complications 1Papillomavirus Infections 1Pancreatic Neoplasms 1Mouth Neoplasms 1Low Anterior Resection Syndrome 1Laryngeal Neoplasms 1Infiltrating Bladder Urothelial Carcinoma 1HPV-Related Squamous Cell Carcinoma 1Fatigue 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1

Interventions

pegfilgrastim 1Gemcitabine 1Cystectomy 1Cisplatin 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Infiltrating Bladder Urothelial Carcinoma × Chemoradiotherapy × 90 days × Clear all
NCT03609216 2026-04-13

Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations

Alliance for Clinical Trials in Oncology

Phase 2 Active not recruiting
237 enrolled
Genitourinary

Infiltrating Bladder Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡